Craig Sherman
General Partner/Managing Director @ Meritech Capital Partners
Palo Alto, United States
Craig Sherman is a Partner and Managing Director at Meritech since 2011. Craig focuses primarily on digital media and consumer services. Craig has led the firm's investments in Evernote, Zulily, Lynda.com and Ariosa Diagnostics. Prior to Meritech, Craig was Chief Executive Officer of Gaia Interactive, which he grew from a 1/2 million to over a 20 million monthly visitor pioneer in social games and online communities. Prior to joining Gaia, Craig served as an Entrepreneur in Residence at Benchmark Capital. Previously, Craig was Chief Operating Officer of Ancestry.com (ACOM), where he helped lead the company’s pivot from a free family social network to a family history subscription service and grew the company from under $10 million to $150 million in sales and from tens of millions in losses to tens of millions in profits. Before Ancestry.com, Craig held senior positions at AIG: he was Head of Marketing and Internet for all of AIG's Japanese and Korean divisions totaling over $5 billion in sales; and the General Manager of AIG's property management software subsidiary, a $90 million sales company whose growth rate quadrupled during Craig's tenure. Previous to AIG, Craig was Chief Executive Officer of Cendant Japan, a joint venture startup he founded with Cendant and Mitsubishi Corporation that he helped grow from inception to over $20 million in sales and profitability. Before that, Craig worked in product, marketing, finance and operations roles at Cendant during its growth from less than a $1 billion to over a $40 billion public company. Craig has personally invested in over a dozen startups including Ancestry, SurveyMonkey, Zillow and Zipcar. In addition, Craig has held independent board and advisory roles with Homestead (prior to its sale to Intuit), Kongregate (GameStop), Logoworks (Hewlett Packard), Netquote (BankRate), and Photobucket (Fox). Craig graduated magna cum laude with A.B. degree in East Asian Studies from Princeton University. Craig spends his 'free' time with his son and daughter - hiking, playing soccer, doing puzzles and even some musical theater. After they go to sleep, he loves to meditate and read classic (AKA “old”) novels.
- Total investments:
- 38
- Last investment:
- Lead investor:
- 37%
Last updated:
For AI agents: llms.txt
Industries Craig Sherman invests in
Stages Craig Sherman invests in
Countries Craig Sherman invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1.3M–$4M
- Series C
- $22M–$200M
- Series D
- $10M–$635M
Investment Focus
Industry
- Software 9 (24%)
- Health Care 8 (21%)
- Medical 6 (16%)
- Gaming 5 (13%)
- Biotechnology 4 (11%)
Stage
- Series C 9 (24%)
- Series D 7 (18%)
- Seed 5 (13%)
- Series A 5 (13%)
- Series B 5 (13%)
Country
- United States 25 (66%)
- Israel 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Glystn is a reliable platform for creator analytics and insights of any scale. The company was founded in 2021 and is headquartered in SAN FRANCISCO, California. | $4M / Seed / Jun 15, 2023 | ||
| Toya is developing multilayer games for girls on a Minecraft platform. The playful learning experience enables girls to become the heroes while revealing the life stories of exceptional women. | $4M / Seed / Sep 08, 2021 | ||
| Pendulum Therapeutics believes therapies developed using evidence-based microbiome science and DNA sequencing can help heal the body from within. Armed with 13 patents and 42 pending, the company introduced its flagship product Pendulum Glucose Control, a medical probiotic, in 2020 and demonstrated its efficacy in lowering blood sugar spikes andreducing A1C in a published clinical trial. Founded in 2013 by a diverse team of scientists with deep microbiology, biochemistry, computational, and clinical expertise, Pendulum has raised $111 million to date from Meritech Capital, Sequoia Capital, True Ventures, Khosla Ventures, AME Cloud Ventures and Mayo Clinic among others. Pendulum Therapeutics is headquartered in San Francisco. | $54M / Series C / Apr 07, 2021 | ||
| Originated from San Francisco, Genetica® is a leading and the fastest growing gene testing company in Asia with leading-edge proprietary technology. | $2.5M / Seed / Mar 10, 2021 | ||
| Aledade is a primary care physician platform to provide everything the doctors to create and run an Accountable Care Organization. Aledade partners with independent, primary care physicians to provide everything the doctors need to create and run an Accountable Care Organization (ACO) from business and practice transformation services to upfrontcapital and a cutting-edge technology platform. The company's customized solutions and continuous on-the-ground support of our physician partners will help doctors in all types of communities across America preserve their autonomy, deliver better care to their patients, reduce overall costs, and keep independent physician practices flourishing.Adelade was founded in 2014 and is headquartered in Bethesda, Maryland, United States. | $100M / Series D / Jan 19, 2021 | ||
| Aledade is a primary care physician platform to provide everything the doctors to create and run an Accountable Care Organization. Aledade partners with independent, primary care physicians to provide everything the doctors need to create and run an Accountable Care Organization (ACO) from business and practice transformation services to upfrontcapital and a cutting-edge technology platform. The company's customized solutions and continuous on-the-ground support of our physician partners will help doctors in all types of communities across America preserve their autonomy, deliver better care to their patients, reduce overall costs, and keep independent physician practices flourishing.Adelade was founded in 2014 and is headquartered in Bethesda, Maryland, United States. | $64M / Series C / Apr 20, 2020 | ||
| Roblox is a platform for online gaming and entertainment that provides a communal digital experience that unites individuals via play. It enables anyone to imagine, create, and have fun with friends as they explore interactive 3D experiences produced by developers using their desktop design tool, Roblox Studio. | $150M / Series G / Feb 26, 2020 | ||
| Bright Health Group is built upon the belief that by aligning the best local resources in healthcare delivery with the financing of care, we can drive a superior consumer experience, optimize clinical outcomes, reduce systemic waste and lower costs. Our differentiated approach is: Built on Alignment, Focused on the Consumer, and Powered byTechnology. We have two market facing businesses: NeueHealth and Bright HealthCare. Through NeueHealth we deliver high-quality virtual and in-person clinical care to nearly 75,000 unique patients through our 61 affiliated risk-bearing primary care clinics. Through Bright HealthCare we offer Medicare and Commercial health plan products to approximately 623,000 consumers in 14 states and 99 markets. We are making healthcare right. Together. | $635M / Series D / Dec 17, 2019 | ||
| Bright Health Group is a health insurance company that delivers affordable healthcare to aging and underserved populations. Bright Health aims to improve the healthcare experience by leveraging technology to streamline operations and enhance member engagement. They focus on building partnerships with health systems and care providers to createintegrated healthcare networks. By forming these partnerships, Bright Health seeks to offer its members a more personalized and coordinated healthcare experience.The company differentiates itself by utilizing data analytics and digital tools to help both its members and healthcare providers make more informed decisions about healthcare. They strive to simplify the complexities of health insurance and improve access to quality care for their customers. | $635M / Series D / Dec 17, 2019 | ||
| 10x Genomics is creating revolutionary DNA sequencing technology to help researchers better identify subtle variations that are overlooked by technologies that shred biological samples into tiny fragments before sequencing the short stretches and using computers to assembling them into a genome. | $35M / Series D / Jan 07, 2019 | ||
| See all 38 investments → | |||
Co-Investors
Meritech Capital provides late-stage venture capital to technology companies. It specializes in the fields of finance, venture capital, and late-stage investment management.
Meritech Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alex Clayton
General Partner
|
|||
Alex Kurland
General Partner
|
|||
Arsham Memarzadeh
General Partner
|
|||
Ashley Paston
Partner
|
|||
|
Craig Sherman
General Partner/Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Craig Sherman invest in?
Craig Sherman invests primarily in Software, Health Care and Medical startups, most often at Series C and Series D stage. Most of the 38 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Craig Sherman invest in?
Craig Sherman typically joins rounds of $1.3M–$4M at Seed, $22M–$200M at Series C and $10M–$635M at Series D. These are whole funding-round sizes, not Craig Sherman's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Craig Sherman took part in.
How do I contact Craig Sherman?
Public channels for Craig Sherman include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Craig Sherman last invest?
The most recent investment recorded for Craig Sherman closed in Jun 2023. Shizune tracks 38 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
